Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB ...

Aurora Cannabis Inc (ACB) reports a robust quarter with significant increases in global medical cannabis revenue and a ...

CA$31.6m (up from CA$24.2m loss in 3Q 2024). Profit margin: 36% (up from net loss in 3Q 2024). EPS: CA$0.57 (up from CA$0.51 ...

Aurora Cannabis (ACB) stock surges 27% in premarket after reporting strong Q3 fiscal 2025 results with record-breaking ...

Shares of Aurora Cannabis Inc. ACB rose 6.36% to $3.68 Tuesday, on what proved to be an all-around positive trading session ...

Aurora Cannabis’ short interest ratio sits at 5.2. This tells us that short interest on the stock is relatively high. It also ...

Basic bullish pattern shows that Aurora Cannabis formed a bullish setup with an impulsive five-wave rally, followed by an ABC ...

Canaccord raised the firm’s price target on Aurora Cannabis (ACB) to C$12.50 from C$10 and keeps a Buy rating on the shares.Maximize Your ...

Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.

TD Securities raised the firm’s price target on Aurora Cannabis (ACB) to C$10 from C$9 and keeps a Buy rating on the shares.Maximize Your ...

Operator Greetings, and welcome to the Aurora Cannabis Inc. third quarter 2025 results conference call. [Operator ...

Aurora Cannabis posted Q3 FY25 net revenue of CA$88.2 million, driven by medical cannabis and plant propagation growth, with ...